Nivolumab (anti-PD-1)
Product Specifications
CAS Number
946414-94-4
Synonyms
BMS-936558, ONO-4538, MDX-1106
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041313-PE 200 µL
RT33, CT (MRPS33, 28S ribosomal protein S33, mitochondrial) (PE) discontinued
Sign In for Pricing
View Details MBS1372064-01 0.02 mg (E-Coli)
Recombinant Aspergillus oryzae Cytosolic Fe-S cluster assembly factor cfd1 (cfd1)
Sign In for Pricing
View Details MBS1372064-02 0.02 mg (Yeast)
Recombinant Aspergillus oryzae Cytosolic Fe-S cluster assembly factor cfd1 (cfd1)
Sign In for Pricing
View Details MBS1372064-03 0.1 mg (E-Coli)
Recombinant Aspergillus oryzae Cytosolic Fe-S cluster assembly factor cfd1 (cfd1)
Sign In for Pricing
View Details